Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at [email protected]. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Piramal Pharma Closes USFDA Inspection at Lexington Facility with VAI Status

Written By Parthika Patel13 April 2026 6:53 PM IST

New Delhi: Piramal Pharma Limited has successfully closed the USFDA inspection at its Lexington, Kentucky manufacturing facility following the receipt...

Codeine Cough Syrup Prices Hit Rs 1,000 in MP After Crackdown Disrupts Illegal Trade

Written By Parthika Patel13 April 2026 6:47 PM IST

New Delhi: Codeine-based cough syrups are being sold at black market prices of up to Rs 1,000 per bottle in parts of Madhya Pradesh's Vindhya region...

Delhi Police Bust Illegal Pharma Drug Racket, Medical Representative Among 3 Held

Assam Man Arrested in Arunachal for Fake Pharmacy Licence Fraud

Written By Parthika Patel13 April 2026 6:42 PM IST

New Delhi: A 33-year-old man from Assam has been arrested by Arunachal Pradesh Police for allegedly duping multiple individuals by promising to...

Gland Pharma Reappoints Naina Lal Kidwai as Independent Director for Second Term

Written By Parthika Patel12 April 2026 11:00 AM IST

New Delhi: Gland Pharma Limited has approved the re-appointment of Naina Lal Kidwai as an Independent Director for a second term of five consecutive...

Torrent Pharma Gets Zero USFDA Observations for Bileshwarpura Oncology Facility

Written By Parthika Patel11 April 2026 11:33 PM IST

New Delhi: Torrent Pharmaceuticals Limited has successfully completed a USFDA inspection at its Bileshwarpura oncology manufacturing facility with...

WBJEE 2026 Correction Window Opens for BPharm Applicants, Edit Forms Till April 12

Written By Parthika Patel11 April 2026 11:27 PM IST

New Delhi: The West Bengal Joint Entrance Examinations Board (WBJEEB) has opened the application correction window for WBJEE 2026, allowing candidates...

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma Plans USD 12 Billion Organon Acquisition, Prepares Binding Bid: Report

Written By Parthika Patel10 April 2026 9:46 PM IST

Mumbai: Sun Pharmaceutical Industries is preparing to submit a binding offer of around USD 12 billion to acquire Organon & Co., in what could...

B.Pharm Student Found Dead in Private College Hostel in Andhra

Written By Parthika Patel10 April 2026 9:34 PM IST

Amaravati: A pharmacy student was found dead in her hostel room in Andhra Pradesh, triggering a police investigation into the circumstances...

Glenmark Secures USFDA Nod for Progesterone Vaginal Inserts, Targets USD 59 Million US Market

Written By Parthika Patel10 April 2026 9:22 PM IST

New Delhi: Glenmark Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Progesterone...

Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets

Written By Parthika Patel10 April 2026 9:14 PM IST

New Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin...

Aurobindo Arm CuraTeQ Reports Positive Phase 3 Results for Xolair Biosimilar BP11

Written By Parthika Patel10 April 2026 9:09 PM IST

New Delhi: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced positive top-line results from its...

Biocon Receives 5 USFDA Observations at Bengaluru Biosimilars Site

Biocon Launches Denosumab Biosimilars Bosaya, Aukelso in US

Written By Parthika Patel9 April 2026 8:33 PM IST

New Delhi: Biocon Limited has announced the commercial launch of its denosumab biosimilars, Bosaya and Aukelso, in the United States, marking a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok